γH2AX and Chk1 Phosphorylation as Predictive Pharmacodynamic Biomarkers of Chk1 Inhibitor-Chemotherapy Combination Treatments

BMC Cancer - United Kingdom
doi 10.1186/1471-2407-14-483
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Tumour Growth Environment Modulates Chk1 Signalling Pathways and Chk1 Inhibitor Sensitivity

Scientific Reports
Multidisciplinary
2016English

Phosphatase Type 2a-Dependent and -Independent Pathways for ATR Phosphorylation of Chk1

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2007English

Identification of Preferred Chemotherapeutics for Combining With a CHK1 Inhibitor

Molecular Cancer Therapeutics
Cancer ResearchOncology
2013English

DNA Damage Induces Chk1-Dependent Threonine-160 Phosphorylation and Activation of Cdk2

Oncogene
Cancer ResearchGeneticsMolecular Biology
2009English

Chk1 Phosphorylation of Metnase Enhances DNA Repair but Inhibits Replication Fork Restart

Oncogene
Cancer ResearchGeneticsMolecular Biology
2014English

Phosphorylation-Dependent Interactions Between Crb2 and Chk1 Are Essential for DNA Damage Checkpoint

PLoS Genetics
EvolutionEcologyGeneticsMolecular BiologyCancer ResearchSystematicsBehavior
2012English

mTORC1/2 and Protein Translation Regulate Levels of CHK1 and the Sensitivity to CHK1 Inhibitors in Ewing Sarcoma Cells

Molecular Cancer Therapeutics
Cancer ResearchOncology
2018English

Nuclear Chk1 Prevents Premature Mitotic Entry

Journal of Cell Science
Cell Biology
2011English

Topotecan Synergizes With CHEK1 (CHK1) Inhibitor to Induce Apoptosis in Ovarian Cancer Cells

BMC Cancer
Cancer ResearchOncologyGenetics
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy